PubRank

Orit Jacobson

Author PubWeight™ 18.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Automated radiochemical synthesis of [18F]FBEM: a thiol reactive synthon for radiofluorination of peptides and proteins. Appl Radiat Isot 2010 1.09
2 Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results. Clin Nucl Med 2014 1.08
3 Molecular imaging of chemokine receptor CXCR4. Theranostics 2013 1.04
4 Reducing health disparities: strategy planning and implementation in Israel's largest health care organization. Health Serv Res 2011 0.99
5 Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy. ACS Nano 2014 0.96
6 Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100. Mol Imaging Biol 2012 0.96
7 Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors. Nucl Med Biol 2004 0.92
8 Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors. Nucl Med Biol 2007 0.92
9 High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors. J Med Chem 2005 0.90
10 Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence. ACS Nano 2015 0.90
11 CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy. Theranostics 2013 0.89
12 Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer. Bioorg Med Chem 2004 0.86
13 One-pot two-step radiosynthesis of a new (18)F-labeled thiol reactive prosthetic group and its conjugate for insulinoma imaging. Mol Pharm 2014 0.85
14 Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide. Amino Acids 2011 0.84
15 64Cu-labeled lissamine rhodamine B: a promising PET radiotracer targeting tumor mitochondria. Mol Pharm 2011 0.82
16 Evaluation of 64Cu-labeled acridinium cation: a PET radiotracer targeting tumor mitochondria. Bioconjug Chem 2011 0.79
17 Molecular targeting of CEACAM6 using antibody probes of different sizes. J Control Release 2012 0.79
18 Feeling vigorous and the risks of all-cause mortality, ischemic heart disease, and diabetes: a 20-year follow-up of healthy employees. Psychosom Med 2010 0.79
19 PET molecular imaging of angiogenesis with a multiple tyrosine kinase receptor-targeted agent in a rat model of myocardial infarction. Mol Imaging Biol 2015 0.78
20 Work-based predictors of mortality: a 20-year follow-up of healthy employees. Health Psychol 2011 0.78
21 Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425. Nucl Med Biol 2011 0.75
22 Suppressing Nanoparticle-Mononuclear Phagocyte System Interactions of Two-Dimensional Gold Nanorings for Improved Tumor Accumulation and Photothermal Ablation of Tumors. ACS Nano 2017 0.75
23 Evaluation of the Nursing Outcomes Classification (NOC)--from theory to practice in Israel. Outcomes Manag 2003 0.75
24 Rational Design of Branched Nanoporous Gold Nanoshells with Enhanced Physico-Optical Properties for Optical Imaging and Cancer Therapy. ACS Nano 2017 0.75